IPCS INCHEM Home

International Agency for Research on Cancer (IARC) - Summaries & Evaluations

ALLYL ISOVALERATE
(Group 3)

For definition of Groups, see Preamble Evaluation.

VOL.: 71 (1999) (p. 1241)

CAS No.: 2835-39-4

5. Evaluation

No epidemiological data relevant to the carcinogenicity of allyl isovalerate were available.

There is limited evidence in experimental animals for the carcinogenicity of allyl isovalerate.

Overall evaluation

Allyl isovalerate is not classifiable as to its carcinogenicity to humans (Group 3).

For definition of the italicized terms, see Preamble Evaluation.

Previous evaluation: Vol. 36 (1985)

Synonym

Last updated: 13 April 1999 





























    See Also:
       Toxicological Abbreviations
       ALLYL ISOVALERATE (JECFA Evaluation)
       Allyl Isovalerate  (IARC Summary & Evaluation, Volume 36, 1985)